RSS Feed
Tags
adaptive trials advertising advisory committees best practices biologics biosimilar biotech BLA cancer Cato BioVentures Cato Research CBER CDER CDRH clinical trials CMC conference DDMAC DIA drug development eCTD efficacy FDA GlobalSubmit guest post guidance IND inspections medical devices NDA NIH nonclinical research oncology outsourcing personalized medicine postmarketing protocol safety slides Social Media statistical analysis transparency venture capital warning letters webinarCategories
Archives
Links
Follow us on Twitter!
- Featured yesterday at Fierce Biotech IT - Cato lists five keys to success in adaptive trials http://bit.ly/aHry0A about 17 hours ago from TweetDeck
- RT @reuters: "Outgunned FDA tries to get tough with drug ads" http://bit.ly/btorHn 08:45:47 PM September 07, 2010 from web
- @MicroConstants Thanks for retweeting! 07:27:43 PM September 07, 2010 from TweetDeckin reply to MicroConstants
- New blog post: August 2010 FDA Guidances - http://ask-cato.com/mg 02:50:26 PM September 07, 2010 from WordTwit Plugin
Tag Archives: Cato Research
Webinar Slides – Nonclinical Drug Development
Yesterday, Cato Research hosted a webinar titled, “Nonclinical Drug Development – A Successful Path Forward.” Senior Toxicologist Sharon Daily, Ph.D. gave a very informative presentation that was followed by some great questions from the audience. As promised, the slides from … Continue reading
Check Out Our New Blog Design
Image via Wikipedia If you’re reading this, then you’re also seeing our new blog design. We’ve replaced the previous WordPress theme (Pearl, available here) with a customized version of the Twenty Ten 1.0 theme that was recently released with WordPress … Continue reading
Cato at BIO 2010
The BIO International Convention is the largest global event for the biotechnology industry. It attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. This year’s … Continue reading
Posted in Conferences and Meetings
Tagged BIO, BIO 2010, biotech, biotechnology, Cato BioVentures, Cato Research, Chicago, CROs, Quebec
Comments Off